Welcome to our dedicated page for Transcat SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding calibration revenue trends or ISO/IEC 17025 compliance costs inside a Transcat Inc 10-K can feel like hunting through a maze of metrology jargon. Investors want the numbers, not another technical manual. Stock Titan鈥檚 platform meets that need head-on: understanding Transcat SEC documents with AI means our algorithms read every footnote and surface what matters in seconds.
Below, you鈥檒l see every filing the moment it hits EDGAR, but raw documents are only half the story. Our AI-powered summaries translate dense disclosures into clear takeaways and link directly to the page, table or exhibit where the data lives. Whether you鈥檙e tracking laboratory acquisitions or distribution margins, the forms are mapped to investor questions:
- Form 10-K: The Transcat annual report 10-K simplified highlights service-versus-distribution revenue, calibration backlog and risk factors.
- Form 10-Q: The Transcat quarterly earnings report 10-Q filing pairs AI charts with our Transcat earnings report filing analysis so you can compare margins quarter over quarter.
- Form 4: AG真人官方-time alerts for Transcat insider trading Form 4 transactions and Transcat Form 4 insider transactions real-time show when executives buy or sell shares; each Transcat executive stock transactions Form 4 is tagged for context.
- Form 8-K: From new ISO-accredited lab openings to bolt-on acquisitions, see Transcat 8-K material events explained in plain English.
- DEF 14A: The Transcat proxy statement executive compensation breaks down pay tied to calibration service growth.
Because every Transcat filing is tagged, cross-referenced and summarized, you can monitor segment expansion, capital expenditure on new calibration labs or shifts in inventory within minutes鈥攏o spreadsheets required. Consider Stock Titan your always-awake analyst: real-time filing updates, expert commentary and AI-powered comparisons across years mean Transcat SEC filings explained simply. Make decisions faster, backed by the complete regulatory record.
Lee D. Rudow, President, CEO and Director of Transcat, Inc. (TRNS), reported multiple equity transactions dated 08/21/2025. The filing shows a disposition of 93,864 shares of Transcat common stock and the grant of several restricted stock unit (RSU) awards that convert one-for-one into common shares: 14,782, 12,500, 3,925, and 8,785 RSUs. Specific vesting schedules are provided for each award, with portions vesting on March 28, 2026, March 27, 2027, and March 25, 2028 as noted.
In addition, a stock option covering 10,000 shares with an exercise price of $63.17 is reported as fully exercisable as of the report date. The report was signed by an attorney-in-fact on behalf of Mr. Rudow on 08/25/2025. The RSU grants are identified as issued under the Transcat, Inc. 2021 Stock Incentive Plan and are described as transactions exempt under Rule 16b-3.
FAQ
What is the current stock price of Transcat (TRNS)?
What is the market cap of Transcat (TRNS)?
